证券记录 · 已归档季度
APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
11被追踪持有人
-2Δ持有人
24.93M持有股份
$545.30M报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -15.4% ·
股份流向 +4.7% ·
净新建仓位 -18.2%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (被动) | 3.94M | -12.9% | $86.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 1.95M | +6.0% | $42.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 1.95M | +6.0% | $42.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Norges Bank ✦ (被动) | 1.57M | +44.9% | $34.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 451.97K | -21.5% | $9.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 262.90K | 新增 | $5.75M | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 224.10K | +99.3% | $4.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 224.10K | +99.3% | $4.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 90.70K | -74.7% | $1.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 34.28K | +41.1% | $749,813 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 23.57K | -72.4% | $515,563 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $5.75M | 0.0% |
已清仓
| Point72 Asset Management | $40.46M | 曾为 0.1% |
| Renaissance Technologies | $8.68M | 曾为 0.0% |
| D. E. Shaw & Co. | $638,200 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 320 持有人, 137.95M 股份, $5.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据